Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Choice of anti-malarial drugs for chemoprevention
ISRCTN11384306Phase 3Recruiting
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hydroxychloroquine, amodiaquine and sulfadoxine + pyrimethamine in malaria (6 arms), sponsored by Liverpool School of Tropical Medicine. Started Oct 2026; status: recruiting.
02
Drugs
hydroxychloroquineamodiaquinesulfadoxine + pyrimethamine
03
Conditions
malaria
Beyond the preview
Go deeper on ISRCTN11384306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11384306.